Home › INSTRUMENTATION LABORATORY COMPANY › HemosIL Fibrinogen-C XL
HemosIL Fibrinogen-C XL
INSTRUMENTATION LABORATORY COMPANY · Model 00020003900 · UDI-DI 08426950087618
KQJ
Prescription
10
510(k) clearances
6
Adverse events
3
Recalls
10
Facilities
Description
HemosIL Fibrinogen-C XL
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-07-21 | Diagnostica Stago, Inc. | Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications. |
| 2017-05-19 | Fisher Diagnostics | An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While |
| 2017-05-19 | Fisher Diagnostics | An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.